Copyright Reports & Markets. All rights reserved.

Global Cardiovascular Interventional Product Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cardiovascular Interventional Product Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Coronary Stent
    • 1.3.3 PTCA Balloon Catheter
    • 1.3.4 Guide Wire
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cardiovascular Interventional Product Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Angina
    • 1.4.3 Miocardial Infarction
    • 1.4.4 Other
  • 1.5 Global Cardiovascular Interventional Product Market Size & Forecast
    • 1.5.1 Global Cardiovascular Interventional Product Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Cardiovascular Interventional Product Sales Quantity (2019-2030)
    • 1.5.3 Global Cardiovascular Interventional Product Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Boston Scientific
    • 2.1.1 Boston Scientific Details
    • 2.1.2 Boston Scientific Major Business
    • 2.1.3 Boston Scientific Cardiovascular Interventional Product Product and Services
    • 2.1.4 Boston Scientific Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Boston Scientific Recent Developments/Updates
  • 2.2 Abbott Laboratories
    • 2.2.1 Abbott Laboratories Details
    • 2.2.2 Abbott Laboratories Major Business
    • 2.2.3 Abbott Laboratories Cardiovascular Interventional Product Product and Services
    • 2.2.4 Abbott Laboratories Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbott Laboratories Recent Developments/Updates
  • 2.3 Medtronic plc
    • 2.3.1 Medtronic plc Details
    • 2.3.2 Medtronic plc Major Business
    • 2.3.3 Medtronic plc Cardiovascular Interventional Product Product and Services
    • 2.3.4 Medtronic plc Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Medtronic plc Recent Developments/Updates
  • 2.4 TERUMO CORPORATION
    • 2.4.1 TERUMO CORPORATION Details
    • 2.4.2 TERUMO CORPORATION Major Business
    • 2.4.3 TERUMO CORPORATION Cardiovascular Interventional Product Product and Services
    • 2.4.4 TERUMO CORPORATION Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 TERUMO CORPORATION Recent Developments/Updates
  • 2.5 NIPRO
    • 2.5.1 NIPRO Details
    • 2.5.2 NIPRO Major Business
    • 2.5.3 NIPRO Cardiovascular Interventional Product Product and Services
    • 2.5.4 NIPRO Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 NIPRO Recent Developments/Updates
  • 2.6 B. Braun Melsungen AG
    • 2.6.1 B. Braun Melsungen AG Details
    • 2.6.2 B. Braun Melsungen AG Major Business
    • 2.6.3 B. Braun Melsungen AG Cardiovascular Interventional Product Product and Services
    • 2.6.4 B. Braun Melsungen AG Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 B. Braun Melsungen AG Recent Developments/Updates
  • 2.7 Cook Medical
    • 2.7.1 Cook Medical Details
    • 2.7.2 Cook Medical Major Business
    • 2.7.3 Cook Medical Cardiovascular Interventional Product Product and Services
    • 2.7.4 Cook Medical Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Cook Medical Recent Developments/Updates
  • 2.8 MicroPort
    • 2.8.1 MicroPort Details
    • 2.8.2 MicroPort Major Business
    • 2.8.3 MicroPort Cardiovascular Interventional Product Product and Services
    • 2.8.4 MicroPort Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 MicroPort Recent Developments/Updates
  • 2.9 Lepu Medical
    • 2.9.1 Lepu Medical Details
    • 2.9.2 Lepu Medical Major Business
    • 2.9.3 Lepu Medical Cardiovascular Interventional Product Product and Services
    • 2.9.4 Lepu Medical Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Lepu Medical Recent Developments/Updates
  • 2.10 JW Medical Systems (JWMS)
    • 2.10.1 JW Medical Systems (JWMS) Details
    • 2.10.2 JW Medical Systems (JWMS) Major Business
    • 2.10.3 JW Medical Systems (JWMS) Cardiovascular Interventional Product Product and Services
    • 2.10.4 JW Medical Systems (JWMS) Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 JW Medical Systems (JWMS) Recent Developments/Updates
  • 2.11 Intecc
    • 2.11.1 Intecc Details
    • 2.11.2 Intecc Major Business
    • 2.11.3 Intecc Cardiovascular Interventional Product Product and Services
    • 2.11.4 Intecc Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Intecc Recent Developments/Updates
  • 2.12 KANEKA
    • 2.12.1 KANEKA Details
    • 2.12.2 KANEKA Major Business
    • 2.12.3 KANEKA Cardiovascular Interventional Product Product and Services
    • 2.12.4 KANEKA Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 KANEKA Recent Developments/Updates
  • 2.13 Sinomed
    • 2.13.1 Sinomed Details
    • 2.13.2 Sinomed Major Business
    • 2.13.3 Sinomed Cardiovascular Interventional Product Product and Services
    • 2.13.4 Sinomed Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Sinomed Recent Developments/Updates
  • 2.14 Lifetech
    • 2.14.1 Lifetech Details
    • 2.14.2 Lifetech Major Business
    • 2.14.3 Lifetech Cardiovascular Interventional Product Product and Services
    • 2.14.4 Lifetech Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Lifetech Recent Developments/Updates
  • 2.15 Gore Medical
    • 2.15.1 Gore Medical Details
    • 2.15.2 Gore Medical Major Business
    • 2.15.3 Gore Medical Cardiovascular Interventional Product Product and Services
    • 2.15.4 Gore Medical Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Gore Medical Recent Developments/Updates

3 Competitive Environment: Cardiovascular Interventional Product by Manufacturer

  • 3.1 Global Cardiovascular Interventional Product Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Cardiovascular Interventional Product Revenue by Manufacturer (2019-2024)
  • 3.3 Global Cardiovascular Interventional Product Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Cardiovascular Interventional Product by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Cardiovascular Interventional Product Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Cardiovascular Interventional Product Manufacturer Market Share in 2023
  • 3.5 Cardiovascular Interventional Product Market: Overall Company Footprint Analysis
    • 3.5.1 Cardiovascular Interventional Product Market: Region Footprint
    • 3.5.2 Cardiovascular Interventional Product Market: Company Product Type Footprint
    • 3.5.3 Cardiovascular Interventional Product Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cardiovascular Interventional Product Market Size by Region
    • 4.1.1 Global Cardiovascular Interventional Product Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Cardiovascular Interventional Product Consumption Value by Region (2019-2030)
    • 4.1.3 Global Cardiovascular Interventional Product Average Price by Region (2019-2030)
  • 4.2 North America Cardiovascular Interventional Product Consumption Value (2019-2030)
  • 4.3 Europe Cardiovascular Interventional Product Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Cardiovascular Interventional Product Consumption Value (2019-2030)
  • 4.5 South America Cardiovascular Interventional Product Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Cardiovascular Interventional Product Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Cardiovascular Interventional Product Sales Quantity by Type (2019-2030)
  • 5.2 Global Cardiovascular Interventional Product Consumption Value by Type (2019-2030)
  • 5.3 Global Cardiovascular Interventional Product Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Cardiovascular Interventional Product Sales Quantity by Application (2019-2030)
  • 6.2 Global Cardiovascular Interventional Product Consumption Value by Application (2019-2030)
  • 6.3 Global Cardiovascular Interventional Product Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Cardiovascular Interventional Product Sales Quantity by Type (2019-2030)
  • 7.2 North America Cardiovascular Interventional Product Sales Quantity by Application (2019-2030)
  • 7.3 North America Cardiovascular Interventional Product Market Size by Country
    • 7.3.1 North America Cardiovascular Interventional Product Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Cardiovascular Interventional Product Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Cardiovascular Interventional Product Sales Quantity by Type (2019-2030)
  • 8.2 Europe Cardiovascular Interventional Product Sales Quantity by Application (2019-2030)
  • 8.3 Europe Cardiovascular Interventional Product Market Size by Country
    • 8.3.1 Europe Cardiovascular Interventional Product Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Cardiovascular Interventional Product Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cardiovascular Interventional Product Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Cardiovascular Interventional Product Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Cardiovascular Interventional Product Market Size by Region
    • 9.3.1 Asia-Pacific Cardiovascular Interventional Product Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Cardiovascular Interventional Product Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Cardiovascular Interventional Product Sales Quantity by Type (2019-2030)
  • 10.2 South America Cardiovascular Interventional Product Sales Quantity by Application (2019-2030)
  • 10.3 South America Cardiovascular Interventional Product Market Size by Country
    • 10.3.1 South America Cardiovascular Interventional Product Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Cardiovascular Interventional Product Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cardiovascular Interventional Product Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Cardiovascular Interventional Product Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Cardiovascular Interventional Product Market Size by Country
    • 11.3.1 Middle East & Africa Cardiovascular Interventional Product Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Cardiovascular Interventional Product Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Cardiovascular Interventional Product Market Drivers
  • 12.2 Cardiovascular Interventional Product Market Restraints
  • 12.3 Cardiovascular Interventional Product Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cardiovascular Interventional Product and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cardiovascular Interventional Product
  • 13.3 Cardiovascular Interventional Product Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cardiovascular Interventional Product Typical Distributors
  • 14.3 Cardiovascular Interventional Product Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cardiovascular Interventional Product market size was valued at US$ 11090 million in 2023 and is forecast to a readjusted size of USD 15220 million by 2030 with a CAGR of 4.7% during review period.
    Global key players of Cardiovascular Interventional Product include Boston Scientific, Abbott Laboratories, Medtronic plc, TERUMO CORPORATION and NIPRO, etc. Top five players occupy for a share about 75%. North America is the largest market, with a share about 47%, followed by Japan and Europe. In terms of product, Coronary Stent is the largest segment, with a share over 62%. In terms of application, Angina is the largest market, with a share over 60%.
    This report is a detailed and comprehensive analysis for global Cardiovascular Interventional Product market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Cardiovascular Interventional Product market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Cardiovascular Interventional Product market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Cardiovascular Interventional Product market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Cardiovascular Interventional Product market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cardiovascular Interventional Product
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cardiovascular Interventional Product market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Abbott Laboratories, Medtronic plc, TERUMO CORPORATION, NIPRO, B. Braun Melsungen AG, Cook Medical, MicroPort, Lepu Medical, JW Medical Systems (JWMS), etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cardiovascular Interventional Product market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Coronary Stent
    PTCA Balloon Catheter
    Guide Wire
    Other
    Market segment by Application
    Angina
    Miocardial Infarction
    Other
    Major players covered
    Boston Scientific
    Abbott Laboratories
    Medtronic plc
    TERUMO CORPORATION
    NIPRO
    B. Braun Melsungen AG
    Cook Medical
    MicroPort
    Lepu Medical
    JW Medical Systems (JWMS)
    Intecc
    KANEKA
    Sinomed
    Lifetech
    Gore Medical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cardiovascular Interventional Product product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cardiovascular Interventional Product, with price, sales quantity, revenue, and global market share of Cardiovascular Interventional Product from 2019 to 2024.
    Chapter 3, the Cardiovascular Interventional Product competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cardiovascular Interventional Product breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Cardiovascular Interventional Product market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiovascular Interventional Product.
    Chapter 14 and 15, to describe Cardiovascular Interventional Product sales channel, distributors, customers, research findings and conclusion.

    Buy now